2012
Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer
Hessman C, Bubbers E, Billingsley K, Herzig D, Wong M. Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer. The American Journal Of Surgery 2012, 203: 649-653. PMID: 22405917, PMCID: PMC4285581, DOI: 10.1016/j.amjsurg.2012.01.003.Peer-Reviewed Original ResearchConceptsAldehyde dehydrogenase 1Cancer stem cellsClinical outcomesLoss of expressionCSC marker aldehyde dehydrogenase 1Advanced stage colorectal cancerMarker expressionMetastatic CRC samplesAmerican Joint CommitteeLate-stage diseaseColorectal cancer progressionEffective therapeutic targetNonmetastatic CRCMetastatic diseaseEarly CRCALDH1 expressionColorectal cancerCancer stageCRC tumorsCRC samplesTumors variesDisease prognosisNonmetastatic tumorsTherapeutic targetJoint Committee
2009
A population-based analysis of surgical and adjuvant therapy for resected gastric cancer: are patients receiving appropriate treatment following publication of the intergroup 0116 results?
Enestvedt C, Diggs B, Shipley D, Thomas C, Billingsley K. A population-based analysis of surgical and adjuvant therapy for resected gastric cancer: are patients receiving appropriate treatment following publication of the intergroup 0116 results? Gastrointestinal Cancer Research : GCR 2009, 3: 233-8. PMID: 21151426, PMCID: PMC3000069.Peer-Reviewed Original ResearchReceipt of chemoradiotherapyAdjuvant therapyAdjuvant chemoradiotherapyIndependent predictorsGastric adenocarcinomaGastric cancerResectable gastric adenocarcinomaModest survival benefitAmerican Joint CommitteeCurrent practice patternsState Cancer RegistryStandard of carePopulation-based analysisAnalysis of survivalGastric cancer treatmentChi-square testBinary logistic regressionEligible patientsN2 diseaseTreatment eraResection typeSurvival benefitLymph nodesAJCC stageCancer Registry